picture this... putting aside all the platforms....
by this time next year if they cure one solid tumour with cd19/ cf33 combo...game on..paradigm shift.. the whole biosector in oncolytics (or other fields) will want to partner with imugene...
it could become a conglomerate company with the ability to buy smaller research entities...
hence no need to wait for buyouts... just continuous licencing of products.
i am a long term holder an investor... and today's share price is really only reflecting value that is 12 months overdue because of covid delays last year
the runway is long...patience is the key..
remember "the ox is slow but the earth is patient..."
Why IMU is a multi multi bagger, page-2033
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |